cepharanthine has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X; Han, L; Jiang, J; Ma, F; Wang, N; Wang, Q; Wang, Y; Zhang, J; Zhou, Y | 1 |
| Akiyama, S; Che, XF; Furukawa, T; Haraguchi, M; Ikeda, R; Jeung, HC; Nakamura, K; Okumura, H; Shibayama, Y; Sumizawa, T; Takeda, Y; Ushiyama, M; Yamada, K; Yamaguchi, T; Zheng, CL | 1 |
2 other study(ies) available for cepharanthine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Downregulation of MDR1 gene by cepharanthine hydrochloride is related to the activation of c-Jun/JNK in K562/ADR cells.
Topics: ATP Binding Cassette Transporter, Subfamily B; Benzylisoquinolines; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; RNA, Messenger; Signal Transduction | 2014 |
Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pancreatic Neoplasms; Tumor Cells, Cultured; Vincristine | 2005 |